Consistent with our findings, chemotherapy-induced DNA damage has been shown to upregulate the expression of miR-21 by activating NF-κB, which enables breast cancer cells to override DNA damage-induced apoptosis and enhances their invasiveness [28]. This evidence concerns the gene NFKB1 and breast cancer.